Stockreport

Concert Pharmaceuticals Announces Notice of Allowance for U.S. Patent Application Related to CTP-543, Lead Candidate for Treatment of Alopecia Areata

Concert Pharmaceuticals, Inc.  (CNCE) 
Last concert pharmaceuticals, inc. earnings: 4/30 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.concertpharma.com/investor-relations
PDF Claims cover pharmaceutical compositions of CTP-543 and methods of treating alopecia areata with CTP-543New patent expected to expire in 2037Concert expects to advance C [Read more]